Eterna Therapeutics
ERNA
#10318
Rank
HK$83.06 M
Marketcap
HK$10.58
Share price
4.62%
Change (1 day)
-73.33%
Change (1 year)

Revenue for Eterna Therapeutics (ERNA)

Revenue in 2025 (TTM): HK$0 Million

According to Eterna Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$0 Million. In 2024 the company made a revenue of HK$4.51 Million an increase over the revenue in the year 2023 that were of HK$0.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eterna Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$0 M-99.83%
2024 HK$4.51 M750.78%
2023 HK$0.53 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Baxter
BAX
HK$85.77 B 1,102,299,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
HK$1.42 B 18,340,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$369.83 B 4,752,507,999.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Techne
TECH
HK$9.46 B 121,673,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
HK$0.13 B 1,710,185.10%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
HK$130.54 B 1,677,599,900.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel